REQUEST A DEMO
Total
USD $0.00
Search more companies

CMG Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: CMG Pharmaceutical Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

CMG Pharmaceutical Co.,Ltd. is engaged in manufacturing, supply and distribution of pharmaceutical products including OTC (Over-the-Counter) and prescription drugs. The company offers antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. CMG Pharmaceutical Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 2001 formerly known as Skynewpharm Co., Ltd.

Headquarters
14 Dosan-Daero 66 Gil, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the CMG Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.skynewpharm.com

Basic Information
Total Employees:
Purchase the CMG Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the CMG Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the CMG Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the CMG Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
August 01, 2001
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Subsidiaries
Matica Hoidings Inc
㈜서울씨알오
㈜차바이오텍
Company Performance
Financial values in the chart are available after CMG Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
19.07%
Total operating revenue
23.64%
Operating profit (EBIT)
173.17%
EBITDA
86.24%
Net Profit (Loss) for the Period
95.33%
Total assets
14.5%
Total equity
1.71%
Operating Profit Margin (ROS)
3.86%
Net Profit Margin
4.94%
Return on Equity (ROE)
2.26%
Debt to Equity Ratio
10.14%
Quick Ratio
-2.18%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?